WWMSC
SGMO

Wagner Wealth Management (South Carolina)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,300
Closed -$57K – 674
2017
Q4 		$57K Buy
+3,300
New +$49.1K 0.04% 210

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s SGMO Position: Q1 2018 in Review

Wagner Wealth Management (South Carolina) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2018, closing a stake of 3,300 shares — an estimated $57K sold.

Wagner Wealth Management (South Carolina) first reported a position in SGMO in Q4 2017 and held it in 1 quarter. The position peaked at $57K in Q4 2017. 208 funds tracked by Wall St. Rank hold SGMO as of Q1 2018.

  • Wagner Wealth Management (South Carolina) reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2018 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 3,300 SANGAMO THERAPEUTICS INC shares in Q1 2018, an estimated $57K.
  • Wagner Wealth Management (South Carolina) first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and held it in 1 quarter.
  • Wagner Wealth Management (South Carolina)'s SANGAMO THERAPEUTICS INC position peaked at $57K in Q4 2017.
  • 208 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2018.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q1 2018, filed 10 May 2018.